In order to enable clinicians to have a comprehensive understanding of Hybrid surgical technology, standardize diagnosis and treatment behaviors, and provide strong support for clinical decision-making. The final draft of the "Asian Expert Consensus on the Treatment of Arch Aortic Lesions Involving Arch by Hybridization" co-sponsored by the Zhongguancun Precision Medicine Foundation and Professor Shu Chang, Director of the Vascular Surgery Center of Fuwai Hospital, Chinese Academy of Medical Sciences, was successfully held on September 22, 2023.

The final meeting was chaired by Professor Shu Chang, Professor Cheng Cai from Tongji Hospital Affiliated to Huazhong University of Science and Technology, Professor Fang Kun from Fuwai Hospital of Chinese Academy of Medical Sciences, Professor Hu Jia from West China Hospital of Sichuan University, Professor Liu Junwei from Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Professor Li Ming from the Second Xiangya Hospital of Central South University, Professor Ni Buqing from the First Affiliated Hospital of Nanjing Medical University, and Faculty of Medicine: Chiang Mai, TH Prof. Amarit Photikun (Thailand), Prof. Raden Suhartono, Cipto Mangunkusumo National Center General Hospital (RSCM) (Indonesia), Faculty of Medicine: Chiang Mai, TH Surin, Chiang Mai University Prof. Woragidpoonpol (Thailand), Prof. Suko Adiarto, Department of Cardiology and Vascular Medicine, University of Indonesia/ Harapan Kita National Cardiovascular (Indonesia), Viet Duc Hospital Tung Son Prof. Nguyen (Viet Nam), Prof. Uoc Nguyen (Viet Nam), Prof. Siriraj Piyamaharajkarun Hospital, Bangkok Worawong Slisatkorn (Thailand), Department of Cardiovascular Surgery, Dozens of domestic and foreign experts and scholars attended the conference, including Professor Saiseikai Yokohamashi Tobu Hospital, Yokohama, Kanagawa, Japan Yasunori lida (Japan).

01.During the meeting, Professor Li Ming shared the "Asian Expert Consensus on the Treatment of Aortic Arch Lesions by Hybridization Technology". Total endovascular management of aortic arch lesions is complex. A single thoracic stent graft is not sufficient for therapeutic purposes. Adjunctive surgeries such as renal technique, fenestration, or branched stent technique. Each has its own limitations, so the concept of a combination of open surgery and minimally invasive endovascular techniques was born. The concept of Hybrid technology mainly includes the following two aspects: the technology uses both open surgical and interventional methods to treat lesions together, or to treat lesions in different parts alone, and the two complement each other to achieve the best results; Surgical means can create convenient and feasible paths or conditions for interventional surgery, as an auxiliary measure, rather than directly interfering with the lesion, and finally directly dealing with the lesion through interventional means and equipment, so as to treat the disease. After mastering the hybrid surgical technique, it is possible to deal with complex aortic pathology, such as some aortic acute type A dissection with some organ hypoperfusion or some high-risk patients. Therefore, it is very important to organize a training program for the hybrid technique, especially for young doctors, and the key to the success of the operation is to choose an individualized surgical method based on the comprehensive conditions of the patient.

02.Professor Hu Jia shared "The Benefits of Hybrid Surgery in the Treatment of Aortic Arch Disease". At present, the treatment methods for aortic arch aneurysm/dissection include endovascular repair technology and traditional open surgery. Compared with traditional open surgery, although endovascular technology has the advantages of less invasiveness and faster recovery, it is also a major problem to solve complications such as endoleakage and stent detachment. Hybridization is a combination of traditional open surgery and endoluminal techniques, and for minimally invasive techniques to repair proximal aortic lesions, hybridization techniques can obtain good short- and medium-term results, but their long-term results need to be closely monitored. The improvement and innovation of endoluminal techniques and devices that are more suitable for the proximal and distal anchoring areas of the ascending aorta can help improve the long-term benefit of patients treated with hybridization technology.

03.Subsequently, under the leadership of Professor Shu Chang, the experts at the meeting fully discussed and optimized the clinical application of hybrid technology and many other aspects, and experts and scholars made suggestions and suggestions to improve the written expression, and expressed their expectation that after the release of the consensus, it can really help clinical medical workers in Asia, so as to benefit patients with vascular diseases.

The successful convening of the final meeting of the "Asian Expert Consensus on the Treatment of Arch Aortic Lesions Involving Arch by Hybrid" marks another important step in the development of hybrid surgical technology in Asia, which is believed to provide clinicians in Asia with more accurate and practical guidance treatment techniques, and also bring good news to the majority of patients.

Thank you Medtronic for your support!